Literature DB >> 26715282

Misconstrued versatility of Ganoderma lucidum: a key player in multi-targeted cellular signaling.

Balraj Singh Gill1, Prateek Sharma1, Raj Kumar2, Sanjeev Kumar3,4.   

Abstract

A Basidiomycetes fungus belonging to polypore family of mushrooms, Ganoderma lucidum (GL), has been known since a long time for their myriad therapeutic indications. Renowned as an invaluable resource of cardinal mycoconstituents they encompass numerous terpenoids polysaccharides and proteins. Possessing the therapeutically potent lanosteroidal skeleton, terpenoids are upheld for their invariable participation in therapeutically diverse bioactivities. Polysaccharides and proteins exhibiting distinguishable bioactivities provide this oriental mushroom with additional edges over immune function and anti-cancer potential. This review is a concerted effort to throw light upon the therapeutic versatility of the fungus, shadowed by various other natural products. An effort has been made towards conglomerating the mycoconstituents decisive for the many activities portrayed by this fungus. More importantly, this review seeks to fathom the inextricable role played by derivatives in modulating signaling cascades such as downregulation of various mitogenic pathways, inhibiting growth factors, or upregulating certain pathways enhancing cellular integrity.

Entities:  

Keywords:  Cancer; Ganoderic acid (GA); Ganoderma lucidum; Polysaccharides; Terpenoids

Mesh:

Substances:

Year:  2015        PMID: 26715282     DOI: 10.1007/s13277-015-4709-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  113 in total

1.  Structural features of immunologically active polysaccharides from Ganoderma lucidum.

Authors:  Xing-Feng Bao; Xue-Song Wang; Qun Dong; Ji-Nian Fang; Xiao-Yu Li
Journal:  Phytochemistry       Date:  2002-01       Impact factor: 4.072

2.  Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum.

Authors:  A Morigiwa; K Kitabatake; Y Fujimoto; N Ikekawa
Journal:  Chem Pharm Bull (Tokyo)       Date:  1986-07       Impact factor: 1.645

3.  Cytotoxic and pro-apoptotic effects of novel ganoderic acid derivatives on human cervical cancer cells in vitro.

Authors:  Ru-Ming Liu; Ying-Bo Li; Jian-Jiang Zhong
Journal:  Eur J Pharmacol       Date:  2012-02-17       Impact factor: 4.432

4.  Effect of polysaccharides from Ganoderma lucidum on streptozotocin-induced diabetic nephropathy in mice.

Authors:  C-Y He; W-D Li; S-X Guo; S-Q Lin; Z-B Lin
Journal:  J Asian Nat Prod Res       Date:  2006-12       Impact factor: 1.569

5.  Cytotoxicity of Ganoderma lucidum triterpenes.

Authors:  T S Wu; L S Shi; S C Kuo
Journal:  J Nat Prod       Date:  2001-08       Impact factor: 4.050

6.  Transcriptionally mediated inhibition of telomerase of fungal immunomodulatory protein from Ganoderma tsugae in A549 human lung adenocarcinoma cell line.

Authors:  Chien-Huang Liao; Yi-Min Hsiao; Chung-Ping Hsu; Meei-Yn Lin; James Chun-Huan Wang; Yu-Lu Huang; Jiunn-Liang Ko
Journal:  Mol Carcinog       Date:  2006-04       Impact factor: 4.784

7.  Ganoderic acid X, a lanostanoid triterpene, inhibits topoisomerases and induces apoptosis of cancer cells.

Authors:  Chyi-Hann Li; Pei-Yu Chen; Ue-Min Chang; Lou-Sing Kan; Woei-Horng Fang; Keh-Sung Tsai; Shwu-Bin Lin
Journal:  Life Sci       Date:  2005-02-25       Impact factor: 5.037

Review 8.  Emerging sulfated flavonoids and other polyphenols as drugs: nature as an inspiration.

Authors:  Marta Correia-da-Silva; Emília Sousa; Madalena M M Pinto
Journal:  Med Res Rev       Date:  2013-03-28       Impact factor: 12.944

9.  Immunomodulator, LZ-8, prevents antibody production in mice.

Authors:  K Kino; T Sone; J Watanabe; A Yamashita; H Tsuboi; H Miyajima; H Tsunoo
Journal:  Int J Immunopharmacol       Date:  1991

Review 10.  Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer.

Authors:  Vivek R Yadav; Sahdeo Prasad; Bokyung Sung; Ramaswamy Kannappan; Bharat B Aggarwal
Journal:  Toxins (Basel)       Date:  2010-10-22       Impact factor: 4.546

View more
  10 in total

Review 1.  Missing link between microRNA and prostate cancer.

Authors:  Balraj Singh Gill; Jimi Marin Alex; Sanjeev Kumar
Journal:  Tumour Biol       Date:  2016-01-28

Review 2.  Ganoderic acid, lanostanoid triterpene: a key player in apoptosis.

Authors:  Balraj Singh Gill; Richa Mehra; Vicky Kumar; Sanjeev Kumar
Journal:  Invest New Drugs       Date:  2017-10-28       Impact factor: 3.850

Review 3.  Vitex negundo and its medicinal value.

Authors:  Balraj Singh Gill; Richa Mehra; Sanjeev Kumar
Journal:  Mol Biol Rep       Date:  2018-10-11       Impact factor: 2.316

4.  Evaluating anti-oxidant potential of ganoderic acid A in STAT 3 pathway in prostate cancer.

Authors:  Balraj Singh Gill; Sanjeev Kumar
Journal:  Mol Biol Rep       Date:  2016-09-17       Impact factor: 2.316

5.  Ganoderic acid targeting multiple receptors in cancer: in silico and in vitro study.

Authors:  Balraj Singh Gill; Sanjeev Kumar
Journal:  Tumour Biol       Date:  2016-09-03

Review 6.  Triterpenes in cancer: significance and their influence.

Authors:  Balraj Singh Gill; Sanjeev Kumar
Journal:  Mol Biol Rep       Date:  2016-06-25       Impact factor: 2.316

7.  Ganoderic acid alleviates chemotherapy-induced fatigue in mice bearing colon tumor.

Authors:  Abudumijiti Abulizi; Ling Hu; Ang Ma; Fang-Yu Shao; Hui-Ze Zhu; Si-Mei Lin; Guang-Ying Shao; Yue Xu; Jian-Hua Ran; Jing Li; Hong Zhou; Dong-Mei Lin; Lian-Fu Wang; Min Li; Bao-Xue Yang
Journal:  Acta Pharmacol Sin       Date:  2021-04-29       Impact factor: 7.169

8.  Anti-tumor and Anti-angiogenic Ergosterols from Ganoderma lucidum.

Authors:  Shaodan Chen; Tianqiao Yong; Yifang Zhang; Jiyan Su; Chunwei Jiao; Yizhen Xie
Journal:  Front Chem       Date:  2017-10-30       Impact factor: 5.221

9.  Cytotoxic lanostane-type triterpenoids from the fruiting bodies of Ganoderma lucidum and their structure-activity relationships.

Authors:  Shaodan Chen; Xiangmin Li; Tianqiao Yong; Zhanggen Wang; Jiyan Su; Chunwei Jiao; Yizhen Xie; Burton B Yang
Journal:  Oncotarget       Date:  2017-02-07

Review 10.  Fungal Mushrooms: A Natural Compound With Therapeutic Applications.

Authors:  Rishi Man Chugh; Pooja Mittal; Namratha Mp; Tanu Arora; Tanima Bhattacharya; Hitesh Chopra; Simona Cavalu; Rupesh K Gautam
Journal:  Front Pharmacol       Date:  2022-07-13       Impact factor: 5.988

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.